Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

4drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: Adebrelimab ×

Adebrelimab

This drug is selected. Its supporting articles are shown below.

Adebrelimab2

Articles mentioning Adebrelimab

2 articles · page 1 of 1

Neoadjuvant hepatic arterial infusion chemotherapy (HAIC) with GEMOX and lenvatinib in combination with adebrelimab for resectable high-risk recurrent intrahepatic cholangiocarcinoma (ICC): study protocol of the NEO-ERA-01 feasibility trial

bmjopen · abstract · 2026-02-23 · 3 matching annotations

98.7%

Adebrelimab lenvatinib oxaliplatin capecitabine gemcitabine Intrahepatic cholangiocarcinoma NCT06208462 ICC Hepatic arterial infusion chemotherapy

…n 85 mg/m² every 3 weeks), lenvatinib (8 mg/day from Day 5) and Adebrelimab (1200 mg on Day 3, every 3 weeks) for 2–4 cycles. Surgery eligi…

Adebrelimab plus capecitabine versus capecitabine monotherapy for adjuvant treatment of high-risk resected cholangiocarcinoma (ACHIEVE): protocol for a phase II, multicentre, randomised controlled trial

bmjgast · abstract · 2025-07-30 · 1 matching annotations

91.1%

Capecitabine adebrelimab Immunotherapy Cholangiocarcinoma NCT06607276 CCA

…arries a high risk of recurrence even after curative resection. Capecitabine is standard adjuvant therapy, but recurrence rates remain signi…